August 29, 2014
Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

Barriers to Treatment Use

Posted on August 27, 2014 by in LifeGuide, Treatment Horizons

LifeGuide [Treatment Horizons] Opening Doors A new survey uncovers barriers to treatment by Chael Needle There’s an old chestnut that goes something like this: People won’t make a change until they want to make a change. In our present context of low treatment rates, change—linking to and staying in care for those aware of their [...]

Hep Advocacy Goes Global

Posted on August 4, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] All Around the World The war on hepatitis goes global by Larry Buhl The hepatitis crisis has been a global one for some time, but 2014 marks a watershed as NGOs, governments, activists, and pharmaceutical companies have set down important markers in how to address the pandemic. And they’re also beginning to [...]

HIV Therapeutic Vaccine Advances

Posted on July 24, 2014 by in LifeGuide, Treatment Horizons

Treatment Horizons Another Kind of Morning HIV therapeutic vaccines try to come of age by Mariel Selbovitz, MPJ, and David Miller Despite over three decades of research on therapeutic vaccines for the treatment of HIV, clinical advances have been slow in coming for this important class of drug. While there are a plethora of therapeutic [...]

Hep A Prevention

Posted on June 24, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Food for Thought Hepatitis A prevention efforts spark controversy by Larry Buhl The hepatitis C virus gets a lot of attention, and rightly so, because it can and does kill. But several high profile outbreak scares from infected restaurant workers has put the less deadly hepatitis A virus (HAV) on the map [...]

New Treatment Guidelines

Posted on June 23, 2014 by in LifeGuide, Treatment Horizons

LifeGuide [Treatment Horizons] New Guidelines Revised treatment strategies address cost, monitoring & choosing a regimen by Chael Needle Revised guidelines for HIV treatment approaches will help you and your physician figure out how to fine-tune your regimen, now or when you might need to do so in the future. Reported in Guidelines for the Use [...]

HCV & Underreporting

Posted on May 13, 2014 by in Hep Talk, LifeGuide

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C virus (HCV) in the U.S. shows that, with a “silent epidemic,” it’s hard to get accurate numbers. A disease that often has no symptoms, and that hits populations [...]

Mood & HIV Risk

Posted on May 8, 2014 by in LifeGuide, Wellness Watch

Better Days A new study looks at changes in mood as they relate to risk & protection by Chael Needle “Happy” is not just a number-one song by Pharrell Williams. Nurturing that emotion across its day-to-day changes may be an essential part of protecting your own and your partners’ sexual health if you are a [...]

Editing Genes for a Cure

Posted on April 11, 2014 by in LifeGuide, Treatment Horizons

Close to the Edit A functional cure candidate modifies genes to create HIV-resistant cells by Chael Needle Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE CARE Center and Chief Medical Officer of World Health Clinicians, doesn’t throw the word “cure” around lightly. As an HIV physician for over thirty years, he remembers when [...]

Cure News

Posted on April 3, 2014 by in Destination: Cure, LifeGuide

News of the Day The latest reports on HIV cure research show momentum by Jeannie Wraight Here’s a look at some of the HIV cure headlines over the past couple months. The ever-growing momentum towards a cure, particularly funding for cure initiatives, is encouraging. Obama redirects $100 million towards HIV cure research At a White [...]

Race to the Hep C Cure

Posted on March 24, 2014 by in Hep Talk, LifeGuide

Race to the Cure Who are the biggest players now in eradicating hepatitis C? by Larry Buhl Beyond the implementation of the Affordable Care Act, one of the biggest healthcare stories of 2013 was the emerging race of pharmaceutical companies to bring new drugs to the market to cure hepatitis C. The advent of direct-acting [...]